Show simple item record

Authordc.contributor.authorAnderson, Craig S. 
Authordc.contributor.authorHeeley, Emma es_CL
Authordc.contributor.authorHuang, Yining es_CL
Authordc.contributor.authorWang, Jiguang es_CL
Authordc.contributor.authorStapf, Christian es_CL
Authordc.contributor.authorDelcourt, Candice es_CL
Authordc.contributor.authorLindley, Richard es_CL
Authordc.contributor.authorRobinson, Thompson es_CL
Authordc.contributor.authorLavados Germain, Pablo Manuel es_CL
Authordc.contributor.authorNeal, Bruce es_CL
Authordc.contributor.authorHata, Jun es_CL
Authordc.contributor.authorArima, Hisatomi es_CL
Authordc.contributor.authorParsons, Mark es_CL
Authordc.contributor.authorLi, Yuechun es_CL
Authordc.contributor.authorWang, Jinchao es_CL
Authordc.contributor.authorHeritier, Stephane es_CL
Authordc.contributor.authorQiang, Li es_CL
Authordc.contributor.authorWoodward, Mark es_CL
Authordc.contributor.authorSimes, John es_CL
Authordc.contributor.authorDavis, Stephen M. es_CL
Authordc.contributor.authorChalmers Barraza, John es_CL
Admission datedc.date.accessioned2014-03-11T20:11:01Z
Available datedc.date.available2014-03-11T20:11:01Z
Publication datedc.date.issued2013
Cita de ítemdc.identifier.citationN Engl J Med 2013;368:2355-65en_US
Identifierdc.identifier.otherDOI: 10.1056/NEJMoa1214609
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/129303
General notedc.descriptionArtículo de publicación ISIen_US
Abstractdc.description.abstractBackground Whether rapid lowering of elevated blood pressure would improve the outcome in patients with intracerebral hemorrhage is not known. Methods We randomly assigned 2839 patients who had had a spontaneous intracerebral hemorrhage within the previous 6 hours and who had elevated systolic blood pressure to receive intensive treatment to lower their blood pressure (with a target systolic level of <140 mm Hg within 1 hour) or guideline-recommended treatment (with a target systolic level of <180 mm Hg) with the use of agents of the physician’s choosing. The primary outcome was death or major disability, which was defined as a score of 3 to 6 on the modified Rankin scale (in which a score of 0 indicates no symptoms, a score of 5 indicates severe disability, and a score of 6 indicates death) at 90 days. A prespecified ordinal analysis of the modified Rankin score was also performed. The rate of serious adverse events was compared between the two groups. Results Among the 2794 participants for whom the primary outcome could be determined, 719 of 1382 participants (52.0%) receiving intensive treatment, as compared with 785 of 1412 (55.6%) receiving guideline-recommended treatment, had a primary outcome event (odds ratio with intensive treatment, 0.87; 95% confidence interval [CI], 0.75 to 1.01; P = 0.06). The ordinal analysis showed significantly lower modified Rankin scores with intensive treatment (odds ratio for greater disability, 0.87; 95% CI, 0.77 to 1.00; P = 0.04). Mortality was 11.9% in the group receiving intensive treatment and 12.0% in the group receiving guideline-recommended treatment. Nonfatal serious adverse events occurred in 23.3% and 23.6% of the patients in the two groups, respectively. Conclusions In patients with intracerebral hemorrhage, intensive lowering of blood pressure did not result in a significant reduction in the rate of the primary outcome of death or severe disability. An ordinal analysis of modified Rankin scores indicated improved functional outcomes with intensive lowering of blood pressure.en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherMassachusetts Medical Societyen_US
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Títulodc.titleRapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhageen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile